Olmetec and Bursitis - a phase IV clinical study of FDA data

Summary:

Bursitis is reported as a side effect among people who take Olmetec (olmesartan medoxomil), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Hydrocortisone Butyrate, and have Psoriatic arthropathy.

The phase IV clinical study analyzes which people have Bursitis when taking Olmetec. It is created by eHealthMe based on reports of 7,816 people who have side effects when taking Olmetec from the FDA, and is updated regularly.

What is Olmetec?

Olmetec has active ingredients of olmesartan medoxomil. It is often used in high blood pressure. eHealthMe is studying from 7,904 Olmetec users. Check the latest studies of Olmetec.

What is Bursitis?

Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder) is found to be associated with 1,173 drugs and 1,049 conditions by eHealthMe. Check the latest studies of Bursitis.

On Jul, 11, 2026

7,816 people reported to have side effects when taking Olmetec.
Among them, 12 people (0.15%) have Bursitis.

Among these 12 people:

How long have people been on Olmetec when they have Bursitis? *

What is the gender of people who have Bursitis when taking Olmetec? *

female: 66.67 %
male: 33.33 %

What is the age of people who have Bursitis when taking Olmetec? *

What are other drugs people take besides Olmetec? *

Remicade: 3 people, 25.00%
Prednisolone: 3 people, 25.00%
Hydrocortisone Butyrate: 3 people, 25.00%
Urso 250: 2 people, 16.67%
Synthroid: 2 people, 16.67%
Simponi: 2 people, 16.67%
Pitavastatin Calcium: 2 people, 16.67%
Plavix: 2 people, 16.67%
Januvia: 1 person, 8.33%
Intal: 1 person, 8.33%

What are other side effects people have besides Bursitis? *

Renal Disorder (kidney disease): 5 people, 41.67%
Infection: 5 people, 41.67%
Fever: 4 people, 33.33%
Hepatitis C: 3 people, 25.00%
Pain: 3 people, 25.00%
Thrombocytopenia (decrease of platelets in blood): 3 people, 25.00%
Tooth Abscess (pus formation in tooth): 3 people, 25.00%
Drug Eruption (adverse drug reaction of the skin): 3 people, 25.00%
Histiocytosis Haematophagic: 3 people, 25.00%
Ascites (accumulation of fluid in the abdominal cavity): 3 people, 25.00%

What are the existing conditions these people have? *

Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 4 people, 33.33%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 25.00%
Hepatitis C: 3 people, 25.00%
Dyslipidaemia (abnormal amount of lipids): 2 people, 16.67%
Cerebral Infarction (less blood supply to brain resulting tissue damage): 2 people, 16.67%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 1 person, 8.33%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 1 person, 8.33%
Iron Deficiency: 1 person, 8.33%
Insomnia (sleeplessness): 1 person, 8.33%
High Blood Cholesterol: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Olmetec and have Bursitis?

- Check whether Bursitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Olmetec:

Olmetec (7,904 reports)

Bursitis treatments and more:

Bursitis (18,537 reports)

Browse all side effects of Olmetec:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Bursitis:

Bursitis (1,173 drugs)

Browse all the conditions that are associated with Bursitis:

Bursitis (1,049 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on olmesartan medoxomil (the active ingredients of Olmetec) and Olmetec (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.